University of Leicester
Leicester, United Kingdom
NCT Number: NCT07643753
What is this study about? The investigators want to see if exercise and education sessions can help children and young people (aged 10-17) with asthma, manage the participants asthma better.
The investigators will place participants that are recruited to this study into one of three groups by a computer (randomly):
Group 1:
Usual Care: Continue with normal asthma treatment.
Group 2:
Education: Usual care + a 45-minute online asthma education class once a week.
Group 3:
Exercise & Education: Usual care + 3 exercise sessions a week and asthma education classes.
Trial opening soon.
Get Notified10 year–17 year
All sexes
Interventional
Not applicable
Leicester, United Kingdom
This research aims to identify if an exercise and/or asthma education programme, called 'Active Airways', is feasible and acceptable in the paediatric asthma patient. Feasibility, the primary outcome of this study, will be evaluated by calculating the percentage of people approached who participate in the intervention (recruitment) and the percentage who complete the intervention (retention and adherence). The investigators also want to see if the Active Airways programme could improve cardiorespiratory fitness, quality of life and lung function, reduce asthma attacks and reduce healthcare use.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Willing and able to consent to participate in the trial
Able to understand written and spoken English
A diagnosis of Mild to Moderate Asthma or Severe Asthma based on the European Respiratory Society (ERS)/ American Thoracic Society (ATS) consensus statement on Severe Asthma
Able to participate in a formal exercise programme
Aged 10-17 years
Able to engage in focus groups
Approximately 130cm tall (to be able to complete cardiopulmonary exercise testing (CPET))
Exclusion criteria
Self-reported uncontrolled severe exercise-induced breathlessness
Required a course of antibiotics or oral corticosteroids within the 4 weeks prior to the study commencing
Children with severe co-morbidities that will not allow them to participate in an exercise programme e.g. Severe neuromuscular disorders, recent fractures or surgeries, cognitive or behavioural conditions.
Participant is unable or unwilling, in the opinion of the investigator, to give informed consent
12 week interval exercise training programme and 12 week education on exercise with asthma
Other names: exercise
education on exercise and asthma
Time frame: 12 weeks
The percentage of children approached who participate in the intervention (recruitment)
Time frame: 12 weeks
The percentage of participants that complete the intervention with a retention rate of >70%
Time frame: 12 weeks
Participant engagement measured through attendance rates.
Time frame: 12 weeks
Device wear time compliance during the 12-week study, aiming for =>10 hours a day
Time frame: 12 weeks
Lived experience of the barriers for children with asthma to taking part in an exercise programme, measured through qualitative focus groups.
Time frame: 12 weeks
Baseline demographics from participants will be recorded from medical records
Time frame: Baseline, 12 weeks, 6 months and 1 year.
Throat samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups. A greater bacterial diversity in the respiratory sample is considered a sign of heathier and more resilient microbial community. This could lead to fewer asthma exacerbations and better asthma control.
Time frame: Baseline, 12 weeks, 6 months and 1 year
Measured through the paediatric quality of life asthma module to measure how asthma affects the health-related quality of life using 28 items divided into 4 domains, higher scores mean better quality of life and lower scores mean greater asthma-related impairment.
Time frame: Baseline, 12 weeks, 6 months and 1 year.
Cardiorespiratory fitness (maximal oxygen uptake measured by VO2 max)
Time frame: Baseline, 12 weeks, 6 months and 1 year.
Nasal samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups. A greater bacterial diversity in the respiratory sample is considered a sign of a heathier and more resilient microbial community. This could lead to fewer asthma exacerbations and better asthma control.
Time frame: Baseline, 12 weeks, 6 months and 1 year.
Stool samples will be taken and microbial analysis for assessing microbial diversity through 16S rRNA sequencing, to provide relative abundance of bacterial groups. A greater bacterial diversity in the stool sample is considered a sign of heathier and more resilient microbial community which could lead to fewer asthma exacerbations and better asthma control.
Time frame: 12 weeks
Lived experience of the motivators for children and young people with asthma to taking part in an exercise programme, measured through qualitative focus groups.
Contact information is provided by the study sponsor or research team.
University of Leicester
Other
The Feasibility of an Exercise and Asthma Educational Programme 'Active Airways' on Health Outcomes in Children and Young People With Asthma With All Severities
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07411261
Asthma, Asthma Childhood
Amiens, France
View Trial DetailsNCT07500246
Asthma, Asthma Childhood
Luxembourg
View Trial DetailsNCT07169071
Asthma, Asthma Childhood
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07559773
Asthma Childhood, Atopic Dermatitis
View Trial Details